ADUS Quote, Financials, Valuation and Earnings

Health Catalyst, Inc. has a net margin of 6.31% compared to Addus HomeCare Corp.'s net margin of -29.13%. Addus HomeCare Corp.'s return on equity of 8.59% beat Health Catalyst, Inc.'s return on equity of -30.29%.

Addus HomeCare Corp. has a consensus price target of $141.50, signalling upside risk potential of 23.95%. On the other hand Health Catalyst, Inc. has an analysts' consensus of $3.94 which suggests that it could grow by 46.63%. Given that Health Catalyst, Inc. has higher upside potential than Addus HomeCare Corp., analysts believe Health Catalyst, Inc. is more attractive than Addus HomeCare Corp..

Addus HomeCare Corp. has a beta of 0.943, which suggesting that the stock is 5.718% less volatile than S&P 500. In comparison Health Catalyst, Inc. has a beta of 1.723, suggesting its more volatile than the S&P 500 by 72.331%.

Addus HomeCare Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Health Catalyst, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare Corp. pays -- of its earnings as a dividend. Health Catalyst, Inc. pays out -- of its earnings as a dividend.

Addus HomeCare Corp. quarterly revenues are $362.3M, which are larger than Health Catalyst, Inc. quarterly revenues of $76.3M. Addus HomeCare Corp.'s net income of $22.8M is higher than Health Catalyst, Inc.'s net income of -$22.2M. Notably, Addus HomeCare Corp.'s price-to-earnings ratio is 24.44x while Health Catalyst, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare Corp. is 1.55x versus 0.58x for Health Catalyst, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Humana, Inc. has a net margin of 6.31% compared to Addus HomeCare Corp.'s net margin of 0.59%. Addus HomeCare Corp.'s return on equity of 8.59% beat Humana, Inc.'s return on equity of 7.3%.

Addus HomeCare Corp. has a consensus price target of $141.50, signalling upside risk potential of 23.95%. On the other hand Humana, Inc. has an analysts' consensus of $287.08 which suggests that it could grow by 13.46%. Given that Addus HomeCare Corp. has higher upside potential than Humana, Inc., analysts believe Addus HomeCare Corp. is more attractive than Humana, Inc..

Addus HomeCare Corp. has a beta of 0.943, which suggesting that the stock is 5.718% less volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.462, suggesting its less volatile than the S&P 500 by 53.84%.

Addus HomeCare Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana, Inc. offers a yield of 1.4% to investors and pays a quarterly dividend of $0.89 per share. Addus HomeCare Corp. pays -- of its earnings as a dividend. Humana, Inc. pays out 35.45% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Addus HomeCare Corp. quarterly revenues are $362.3M, which are smaller than Humana, Inc. quarterly revenues of $32.6B. Addus HomeCare Corp.'s net income of $22.8M is lower than Humana, Inc.'s net income of $194M. Notably, Addus HomeCare Corp.'s price-to-earnings ratio is 24.44x while Humana, Inc.'s PE ratio is 23.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare Corp. is 1.55x versus 0.24x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Option Care Health, Inc. has a net margin of 6.31% compared to Addus HomeCare Corp.'s net margin of 3.61%. Addus HomeCare Corp.'s return on equity of 8.59% beat Option Care Health, Inc.'s return on equity of 15.16%.

Addus HomeCare Corp. has a consensus price target of $141.50, signalling upside risk potential of 23.95%. On the other hand Option Care Health, Inc. has an analysts' consensus of $35.30 which suggests that it could grow by 16.66%. Given that Addus HomeCare Corp. has higher upside potential than Option Care Health, Inc., analysts believe Addus HomeCare Corp. is more attractive than Option Care Health, Inc..

Addus HomeCare Corp. has a beta of 0.943, which suggesting that the stock is 5.718% less volatile than S&P 500. In comparison Option Care Health, Inc. has a beta of 0.796, suggesting its less volatile than the S&P 500 by 20.434%.

Addus HomeCare Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare Corp. pays -- of its earnings as a dividend. Option Care Health, Inc. pays out -- of its earnings as a dividend.

Addus HomeCare Corp. quarterly revenues are $362.3M, which are smaller than Option Care Health, Inc. quarterly revenues of $1.4B. Addus HomeCare Corp.'s net income of $22.8M is lower than Option Care Health, Inc.'s net income of $51.8M. Notably, Addus HomeCare Corp.'s price-to-earnings ratio is 24.44x while Option Care Health, Inc.'s PE ratio is 24.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare Corp. is 1.55x versus 0.91x for Option Care Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx Corp. has a net margin of 6.31% compared to Addus HomeCare Corp.'s net margin of 2.99%. Addus HomeCare Corp.'s return on equity of 8.59% beat OptimizeRx Corp.'s return on equity of 0.03%.

Addus HomeCare Corp. has a consensus price target of $141.50, signalling upside risk potential of 23.95%. On the other hand OptimizeRx Corp. has an analysts' consensus of $24.33 which suggests that it could grow by 69.93%. Given that OptimizeRx Corp. has higher upside potential than Addus HomeCare Corp., analysts believe OptimizeRx Corp. is more attractive than Addus HomeCare Corp..

Addus HomeCare Corp. has a beta of 0.943, which suggesting that the stock is 5.718% less volatile than S&P 500. In comparison OptimizeRx Corp. has a beta of 1.099, suggesting its more volatile than the S&P 500 by 9.906%.

Addus HomeCare Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare Corp. pays -- of its earnings as a dividend. OptimizeRx Corp. pays out -- of its earnings as a dividend.

Addus HomeCare Corp. quarterly revenues are $362.3M, which are larger than OptimizeRx Corp. quarterly revenues of $26.1M. Addus HomeCare Corp.'s net income of $22.8M is higher than OptimizeRx Corp.'s net income of $779K. Notably, Addus HomeCare Corp.'s price-to-earnings ratio is 24.44x while OptimizeRx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare Corp. is 1.55x versus 2.46x for OptimizeRx Corp.. Usually stocks with elevated PS ratios are considered overvalued.